Gout and organ transplantation

Area of Science:

• Nephrology
• Rheumatology
• Transplantation Medicine

Background:

• Gout is a common complication in organ transplant recipients.
• Risk factors include general population factors (e.g., diuretic use) and transplant-specific factors (e.g., cyclosporine).

Purpose of the Study:

• To review the clinical features, diagnosis, and management of gout in organ transplant recipients.
• To highlight the importance of distinguishing gout from septic arthritis and managing long-term serum urate levels.

Main Methods:

• Literature review of gout in organ transplant patients.
• Analysis of risk factors, clinical presentation, diagnostic criteria, and treatment options.

Main Results:

• Clinical features are similar to the general population, with tophi potentially being more common.
• Diagnosis requires monosodium urate crystal identification; empiric treatment is common, but joint aspiration is crucial if septic arthritis is suspected.
• Corticosteroids are preferred for acute flares due to NSAID/colchicine interactions. Long-term management focuses on serum urate reduction (≤6 mg/dL) using agents like allopurinol, with careful monitoring when used with azathioprine.

Conclusions:

• Gout management in transplant recipients requires careful consideration of drug interactions and immunosuppressive regimens.
• Long-term control of hyperuricemia is essential for preventing recurrent gout flares and managing chronic disease.
• Minimizing diuretic use is a key general measure.